Physician

Hilary Smolen Brader, MD

According to 2025 Medicare claims, Hilary Brader, MD (NPI: 1114247343) practices ophthalmology in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Philadelphia, PA. This provider's primary affiliated billing organization is KAY & TABAS OPHTHALMOLOGY ASSOCIATES (NPI: 1386647105; TIN: 232148414) and primary practice location at 19004-1704.

Brader's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 602 traditional Medicare patients, billed 10,934 HCPCS/CPT codes, and received $1,069,983 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 177 prescription claims across 52 beneficiaries totaling $24,805 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 26 records totaling $580. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $90,176 to $1,069,983. Similarly, Part D prescription costs have risen steadily, from $2,689 to $24,805. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$607K$1.2M2016 Medicare payment: $90,176 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $700,281 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $807,799 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $693,403 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $967,092 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,213,317 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $968,706 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $866,662 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,069,983 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
201685418$90,176
20174254,050$700,281
20184844,890$807,799
20195034,390$693,403
20207415,529$967,092
20217906,637$1,213,317
20228316,197$968,706
202358612,091$866,662
202460210,934$1,069,983

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$15K$30K2015 Drug cost: $2,689 (USD; Tot_Drug_Cst)2016 Drug cost: $610 (USD; Tot_Drug_Cst)2017 Drug cost: $7,857 (USD; Tot_Drug_Cst)2018 Drug cost: $9,122 (USD; Tot_Drug_Cst)2019 Drug cost: $12,903 (USD; Tot_Drug_Cst)2020 Drug cost: $22,772 (USD; Tot_Drug_Cst)2021 Drug cost: $30,068 (USD; Tot_Drug_Cst)2022 Drug cost: $27,765 (USD; Tot_Drug_Cst)2023 Drug cost: $23,485 (USD; Tot_Drug_Cst)2024 Drug cost: $24,805 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151963$2,689
2016N/R11$610
201738119$7,857
20183290$9,122
201944113$12,903
202047124$22,772
202161175$30,068
202267167$27,765
202347131$23,485
202452177$24,805

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more5851,192$95
67028Injection of drug into eye98637$92
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more55116$75
92134Imaging of retina5591,427$31
92250Photography of the retina186240$28

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate451,965$2,299
DifluprednateDifluprednate11194$975
Dorzolamide HclDorzolamide Hcl13781$192
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat181,199$157
ErythromycinErythromycin Base13301$131

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.26$580Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Hilary Smolen Brader, MD?

Tedicare shows public-source Medicare data for Hilary Smolen Brader, MD (NPI 1114247343), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Hilary Smolen Brader, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Hilary Smolen Brader, MD?

Hilary Smolen Brader, MD is linked to KAY & TABAS OPHTHALMOLOGY ASSOCIATES (billing NPI 1386647105) in the available physician profile data.

Does Hilary Smolen Brader, MD have Open Payments data?

Hilary Smolen Brader, MD has 26 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.